-
2 Cannabis Stocks Becoming Popular Short-Seller Targets
Tuesday, October 23, 2018 - 2:57pm | 406FIS Astec Analytics’ latest batch of short seller data revealed a pair of popular marijuana stocks are among the hottest stocks to short these days. The Most Popular According to FIS Astec, Tilray Inc (NASDAQ: TLRY) is the most popular stock among short sellers after gaining 299 percent in...
-
Walmart Conducted 'Preliminary Fact-Finding' For Selling Marijuana Products In Canada
Tuesday, October 9, 2018 - 12:41pm | 352Just days ahead of the full legalization of cannabis in Canada, the Canadian arm of retail giant Walmart Inc (NYSE: WMT) confirmed it looked into selling cannabis products in its stores. What Happened Canadians may be able to purchase cannabis at some point in the future at Walmart stores, although...
-
Youngevity Surges On Announcement Of CBD Beverage Products
Thursday, October 4, 2018 - 11:56am | 411Lifestyle company Youngevity International (NASDAQ: YGYI) offers products in retail categories such as health and nutrition, spa and beauty and food and beverage. What Happened Youngevity announced plans Thursday to expand its cannabidiol line HEMPFX with the launch of two ...
-
GW Pharma's Epidiolex Becomes First CBD To Get DEA Rescheduling
Thursday, September 27, 2018 - 11:19am | 514Amid the controversies surrounding the legalization of cannabis and associated products, gradual advancements have been made this year. As of Sept. 27, a specific type of cannabidiol, or CBD oil will be federally legal in the United States. What Happened The U.S. Drug Enforcement Administration...
-
GW Pharma's Epidiolex Becomes First Cannabis-Based FDA-Approved Drug
Monday, June 25, 2018 - 1:06pm | 542As expected, the U.S. Food and Drug Administration on Monday approved GW Pharmaceuticals PLC-ADR (NASDAQ: GWPH)'s Epidiolex for the treatment of epilepsy, specifically for people who suffer with Lennox-Gastaut and Dravet syndromes. Why It’s Important The drug is derived from the...
-
Why GW Pharma's Epidiolex Results Could Shape The Future Of Cannabis-Based Therapeutics
Thursday, January 25, 2018 - 4:51pm | 1039Medical journal The Lancet published an article Wednesday that could mold the future of cannabis-derived therapeutics. The piece in question featured results from GW Pharmaceuticals PLC- ADR (NASDAQ: GWPH) and Greenwich Biosciences’ Phase 3 study of Epidiolex — an oral cannabidiol...
-
It's High Time For Zynerba Positives: Investors Await 3 Key Mid-Stage Trial Reads On Cannabidiol ZYN002
Monday, March 27, 2017 - 4:07pm | 488Zynerba Pharmaceuticals Inc (NASDAQ: ZYNE) is about to embark upon a journey with unknown destinations, as investors brace for a trio of reads from the company in the third quarter of 2017. Focus: 3 Phase 2 Reads Of ZYN002 Cantor Fitzgerald said in a note released Monday it remains focused on...
-
GW Pharma Takes A Step Toward Diversifying
Tuesday, February 7, 2017 - 10:28am | 568Being a one-trick pony can always prove risky. This rationale seems to have dawned on GW Pharmaceuticals PLC- ADR (NASDAQ: GWPH), a biopharmaceutical company specializing in prescription cannabinoid medicine. Risk Mitigation Through Diversification The company announced Tuesday positive top...
-
New Study Shows Marijuana May Help Fight Cancer
Friday, June 19, 2015 - 11:31am | 318Israel-based One World Cannabis Ltd. has developed a cannabinoid-based drug therapy that was shown to be effective in fighting multiple myeloma cells. In clinical trials, a combination of cannabidiol (CBD) and tetrahydrocannabinol (THC) was able to decrease the survival of cancerous cells, a big...
-
The Hemp Industry Struggles To Find Its Place
Thursday, June 4, 2015 - 1:06pm | 340With medical and recreational marijuana quickly becoming a booming business in the U.S., farmers with newly issued licenses to grow hemp are finding it difficult to carve out their own place in the market. Hemp farmers in several states are beginning their second growing season this year, though...
-
Terra Tech To Discuss Its Marijuana Opportunities At WeedStock Conference
Thursday, June 5, 2014 - 4:32pm | 378Terra Tech (OTC: TRTC) announced Thursday it will be participating in the first annual WeedStock conference presented by Marketfy. That conference will take place in Denver, Colorado, from June 29 through July 1. Terra Tech is poised to transform itself from a vegetable producer to a...
-
Terra Tech CEO Derek Peterson: CBD Extraction 'Not Where It Needs To Be'
Wednesday, April 9, 2014 - 4:15pm | 1365(Note: This is the second of a two-part interview with Terra Tech Corp. CEO Derek Peterson. Click here for part one) Terra Tech Corp (OTC: TRTC), and its subsidiary, GrowOp Technology Ltd, is working on the development of a CBD supplement with the medical research firm Intergetics (OTC: NRTI...